Plain-English translation of NCT07007338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing cinacalcet, a medication already used in Europe to help children on dialysis manage a condition where the parathyroid glands produce too much hormone. Researchers want to see whether cinacalcet not only lowers hormone levels but also improves how calcium is stored in bones—something that hasn't been clearly measured before in children. They'll use a special blood test that measures calcium isotopes (natural variations of calcium) to track changes in bone health.
Children on dialysis often have problems with bone and mineral balance that can lead to weak bones and heart problems. While this medication has been shown to work in adults, doctors need to understand better whether it truly helps children's bones stay healthy and strong, not just whether it lowers hormone levels.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would begin taking cinacalcet as your doctor has already decided to prescribe it. The main difference is that researchers will also collect blood samples to perform the special calcium isotope test at different time points to see how the medication affects your bone calcium balance. The study will follow you as you take the medication, combining standard dialysis care with this new way of measuring how your bones are responding to treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France